HiCenter Ventures
VC Fund
Haifa, Israel
HiCenter Ventures is a VC fund in Haifa focused on Software and Health Care. HiCenter leads entrepreneurial, business, and technological activities in Haifa innovation district, supporting entrepreneurs in developing their startups and build successful companies. HiCenter operates as a dynamic investment hub with the capability to connect companies to multi-funding opportunities, linking investors to breakthroughtechnologies, driving the growth of startups, and facilitating their progression to the next stage. Today, HiCenter plays a central role in accelerating the technological entrepreneurial ecosystem in Haifa through a synergistic collaboration with the city’s key institutions and partners.
- Total investments:
- 36
- Last investment:
- Lead investor:
- 3%
Last updated:
For AI agents: llms.txt
Industries HiCenter Ventures invests in
Stages HiCenter Ventures invests in
Countries HiCenter Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Gil Rifkin
|
|||
Lior Hanuka
|
|||
Investment Focus
Industry
- Software 9 (25%)
- Health Care 9 (25%)
- Artificial Intelligence 8 (22%)
- Medical Device 6 (17%)
- Information Technology 6 (17%)
Stage
- Seed 28 (78%)
- Pre-Seed 4 (11%)
- Venture - Series Unknown 2 (6%)
- Series A 1 (3%)
Country
- Israel 30 (83%)
- Brazil 1 (3%)
- United States 1 (3%)
- United Kingdom 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Gil Rifkin
Business Development Manager
|
Business Development Manager | Total investments: 0 | Find email | |
|
Lior Hanuka
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
THETIS AI
|
THETIS AI is an advanced maritime technology solution that integrates with onboard navigation and performance systems. | $3M / Seed / Jun 01, 2025 | |
Exosomm
|
Exosomm is an advanced foodtech start-up. Exosomm develops food solutions based on natural milk exosomes, which are backed by research at Hadassah Medical Center conducted by Prof. Reif's team. Exosomm’s first product is a food formula with a patented-based active anti-inflammatory effect designed for patients with inflammatory bowel diseases(Crohn´s & Colitis). | $90K / Seed / Mar 04, 2025 | |
Engini
|
Engini is a technology company specializing in no-code automation and integration solutions for businesses. The company provides a platform that enables organizations to automate workflows and integrate various software systems without the need for coding. Engini supports integration with a wide range of ERP and SaaS applications, includingSalesforce, QuickBooks, Shopify, and Priority ERP, allowing for seamless data flow and process synchronization across platforms. | $90K / Seed / Feb 26, 2025 | |
EndoCure
|
EndoCure is a endometriosis diagnostic, and a novel robotic AI-powered ultrasound is revolutionizing the field. | $90K / Seed / Feb 26, 2025 | |
NayamWings
|
NayamWings introduces a new breed of wind propulsion for merchant ships that seeks to greatly minimize fuel consumption and emissions. Our wing design utilizes advanced airfoil shapes and an asymmetric configuration, enabling powerful thrust as a hybrid propulsion system in maritime vessels. Aircraft technology Wind Propulsion system for maritimevessels. * 35% fuel and emission reduction for new build ships * 15%-25% for retrofitted ships * Fully Autonomous * Heeling control | $150K / Seed / Dec 24, 2024 | |
Droxi
|
Droxi is an AI-based platform that helps primary care physicians to reduce the amount of time spent on non-patient-facing tasks. | $21M / Series A / Dec 03, 2024 | |
|
Carbon Blue
|
Carbon Blue is developing an 'ocean-capture' scalable method for removing CO2 from the atmosphere. The company was founded by Iddo Tsur and Dan Deviri. | $100K / Seed / Oct 16, 2024 | |
Vigor Medical Technologies
|
Vigor Medical Technologies Ltd. develops and will commercialise life saving innovative devices for treatment of chest trauma and for thoracic/abdominal drainage. According to World Health Organization (WTO) over 4 Million cases of chest trauma occure worldwide annually and it is the leading cause of accidental death. Vigor'sself-fixation sealing devices prevent lung and heart collapse, both of which are fatal if not immediately identified, treated and reassessed for effective management in the hospital. | $110K / Seed / Oct 09, 2024 | |
Nurami Medical
|
Nurami Medical is dedicated to the development of a surgical scaffold platform for the repair, regeneration and safe healing of soft tissues following internal surgeries. Nurami Medical production technology is based on the electrospinning technique. | $110K / Seed / Sep 12, 2024 | |
Valid.it
|
Valid.it is a software company that specializes in building AI platforms. The company was founded in 2021 and is based in Tel Aviv, Israel. | $130K / Seed / Aug 16, 2024 | |
| See all 36 investments → | |||
Co-Investors
AirAngels
1 deal together
Crescendo Venture Partners
1 deal together
Drive Capital
1 deal together
Elements° VC
1 deal together
fresh.fund
1 deal together
Galil Ofek
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does HiCenter Ventures invest in?
HiCenter Ventures invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Seed and Pre-Seed stage. Most of the 36 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact HiCenter Ventures?
Public channels for HiCenter Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at HiCenter Ventures?
The team at HiCenter Ventures includes Gil Rifkin (Business Development Manager) and Lior Hanuka (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
